BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37228600)

  • 1. Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies.
    Li M; Zhang Y; Zhang W; Sun J; Liu R; Pan Z; Zhang P; Liu S
    Front Immunol; 2023; 14():1169057. PubMed ID: 37228600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
    Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
    Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
    Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
    BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features.
    Torres-Ruiz J; Carrillo-Vazquez DA; Padilla-Ortiz DM; Vazquez-Rodriguez R; Nuñez-Alvarez C; Juarez-Vega G; Gomez-Martin D
    J Transl Med; 2020 Mar; 18(1):125. PubMed ID: 32164729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis.
    Zhang P; Li M; Zhang Y; Lian C; Sun J; He Y; Hu W; Wang L; Li T; Liu S; Zhang Y
    Clin Rheumatol; 2023 Aug; 42(8):2145-2154. PubMed ID: 37160775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies.
    Wilfong EM; Bartkowiak T; Vowell KN; Westlake CS; Irish JM; Kendall PL; Crofford LJ; Bonami RH
    Front Immunol; 2022; 13():756018. PubMed ID: 35371068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy.
    Izuka S; Komai T; Shoda H; Fujio K
    Rheumatol Int; 2023 Feb; 43(2):335-343. PubMed ID: 36175662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
    Zhao L; Su K; Liu T; Sun D; Jiang Z
    Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Value of
    Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
    Front Immunol; 2021; 12():745211. PubMed ID: 34867971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Profiling of Immune Cell Types in Peripheral Blood Reveals Common and Specific Pathways Involved in the Pathogenesis of Myositis-Specific Antibody-Positive Inflammatory Myopathies.
    Sugimori Y; Iwasaki Y; Takeshima Y; Okubo M; Kobayashi S; Hatano H; Yamada S; Nakano M; Yoshida R; Ota M; Tsuchida Y; Nagafuchi Y; Shimane K; Yoshida K; Kurosaka D; Sumitomo S; Shoda H; Yamamoto K; Okamura T; Fujio K
    ACR Open Rheumatol; 2023 Feb; 5(2):93-102. PubMed ID: 36651871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients.
    Qian J; Li R; Chen Z; Cao Z; Lu L; Fu Q
    Front Immunol; 2023; 14():1151695. PubMed ID: 37006269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes.
    Liu D; Zhao L; Jiang Y; Li L; Guo M; Mu Y; Zhu H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2456-2472. PubMed ID: 35860906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy.
    Huo T; Yuan X; Han J; Shi J; Xiong Y; Tian F; Xu Z; Cai M; Xu Y; Chen H; Zeng X; He W; Wang Q; Zhang J
    Front Immunol; 2023; 14():1188257. PubMed ID: 37377960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
    Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
    Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
    PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies.
    Seto N; Torres-Ruiz JJ; Carmona-Rivera C; Pinal-Fernandez I; Pak K; Purmalek MM; Hosono Y; Fernandes-Cerqueira C; Gowda P; Arnett N; Gorbach A; Benveniste O; Gómez-Martín D; Selva-O'Callaghan A; Milisenda JC; Grau-Junyent JM; Christopher-Stine L; Miller FW; Lundberg IE; Kahlenberg JM; Schiffenbauer AI; Mammen A; Rider LG; Kaplan MJ
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 31945019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.